CV Earnings Date: Nov 12, 2026 (Estimated) — CapsoVision, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is CV's next earnings date?
CapsoVision, Inc. (CV) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.15 on revenue of $3.7M.
How did CV do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), CapsoVision, Inc. posted EPS of -$0.15 versus the -$0.13 estimate, a miss of 15.4%. Revenue was $3.6M against a $3.8M estimate. The stock's 1-day post-earnings move was -4.9%.
How much does CV stock move after earnings?
CV beat EPS estimates in 1 of its last 4 reported quarters. Over the last 5 reports the stock moved an average of 6.1% (up or down) in the day after earnings.
About CapsoVision, Inc.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.13 | -0.15 | -15.38% | $3.6M | ❌ Miss | -4.86% | -12.96% | -4.12% |
| 2026-05-14 | Q1 2026 | -0.13 | -0.15 | -15.38% | $2.8M | ❌ Miss | -11.58% | -7.26% | -0.96% |
| 2026-03-26 | Q4 2025 | -0.15 | 0.02 | +113.33% | $3.9M | ✅ Beat | -0.27% | -1.20% | -15.40% |
| 2025-11-13 | Q3 2025 | -0.13 | -0.17 | -30.77% | $3.5M | ❌ Miss | -9.70% | -6.00% | +143.03% |
| 2025-08-14 | Q2 2025 | — | -2.02 | — | $3.3M | — | -4.23% | -0.99% | +7.71% |
Showing last 5 quarters.
Revenue by segment & region
By region
Q2 FY26 · $3.1M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 81.7% | $2.5M | +7.4% | $2.5M | $4.9M | $1.7M | $2.5M |
| FRANCE | 13.2% | $407K | — | — | — | $311K | $407K |
| GERMANY | 5.1% | $157K | — | — | — | $255K | $157K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.